☆
4.8
Editorial Material
Osimertinib as First-Line Treatment in EGFR-Mutated Non-Small-Cell Lung Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2018)
导出引文
没有可用的引文
评价这篇论文
主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started